The National Stock Exchange has filed its draft prospectus with Sebi, moving closer to its long-awaited Initial Public Offering. The IPO is...

Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...

Germany requires international students and job seekers to open a blocked account, known as a Sperrkonto, to prove financial self-sufficien...

Top global investors like SoftBank and KKR have cashed out nearly Rs 18,000 cr from new-age Indian companies post-listing. This marks a shi...

Private sector banks are attracting investors with robust credit growth and stable asset quality. Experts anticipate a rate cycle shift, bo...

A preliminary deal to end the Middle East war boosted global risk appetite, sending oil prices down and the U.S. dollar near 10-day lows. I...

The Indian rupee reached a five-week high on Monday. Benchmark bond yields fell to their lowest since mid-April. This surge followed news o...

A US-Iran peace framework has sparked a sharp rally in Indian markets, sending crude oil prices lower, strengthening the rupee and promptin...

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

The Indian rupee experienced a robust uptick against the dollar on Friday, sparked by newfound optimism regarding peace talks between the U...

Lenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...

ADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...

Eyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...

Abu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...

Abu Dhabi Investment Authority (ADIA) is set to divest up to 2.3% of its stake in eyewear retailer Lenskart for approximately Rs 1,944 cror...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...